Despite daily improvements, Edwards Lifesciences Corp. underperforms competition Thursday 2023

Shares of Edwards Lifesciences Corp. EW, +0.52% increased by 0.52% to $83.88 on Thursday, during a generally positive session for the stock market, with the S&P 500 Index SPX, +0.36% increasing by 0.36% to 4,105.02 and the Dow Jones Industrial Average DJIA, +0.01% increasing by 0.01% to 33,485.29. The stock rose for the third straight day. Edwards Lifesciences Company ended April 21 $47.22 below its 52-week high of $131.10.

Comparing the stock’s performance to that of its competitors on Thursday, Abbott Laboratories ABT, +0.69% rose to $104.93, Medtronic PLC MDT, +0.04% rose to $80.30, and Stryker Corp. SYK, -0.12% fell to $276.68. Volume remained 2.1 million below its 50-day average volume of 3.7 million.

Leave a Comment